D
Deerfield
OtherActiveDeerfield is an investment management firm, committed to advancing healthcare through investment, information and philanthropy.
90
Investments
45
Exits
—
AUM
50.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Deerfield.
Investment Thesis & Strategy
Deerfield invests in various stages of biotech and healthcare companies, seeking to advance healthcare through investment and information.
Investment Activity
Deals per year over the last 8 years
2
20163
20171
20180
20192
20200
20213
20221
2023Portfolio Companies
Selected investments from their portfolio of 90 companies
A
Alumis
Biotech · Series B, 2023
A
Apogee Therapeutics
Biotech · Series A, 2022
R
Rgenta Therapeutics
Biotech · Series A, 2022
K
Kyverna Therapeutics
Biotech · Series B, 2022
T
Triumvira Immunologics
Biotech · Series A, 2020
V
Ventyx Biosciences
Biotech · Series A, 2020
C
Cerevel Therapeutics
Biotech · Series A, 2018
T
Turning Point Therapeutics
Biotech · Series A, 2017
O
Obsidian Therapeutics
Biotech · Series A, 2017
G
Gossamer Bio
Biotech · Series A, 2017
L
Lyra Therapeutics
Biotech · Series A, 2016
R
Rani Therapeutics
Biotech · Series A, 2016
Frequently Asked Questions
Deerfield invests across multiple stages. Sign up to view detailed stage data.